Form 4: Agilent Director Podolsky Boosts Stake with Share Acquisition

Agilent Technologies Director Daniel K. Podolsky acquired 2,158 shares of common stock at $111.75 per share, increasing his beneficial ownership.

Summary

• Daniel K. Podolsky, a Director at Agilent Technologies, Inc. (A), acquired 2,158 shares of common stock on March 19, 2026.
• The shares were acquired at a price of $111.75 per share.
• This acquisition was part of an award for Non-Employee Directors, fully vested upon grant, with the reporting person electing to defer receipt.
• An additional 285.092 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan, also deferred.
• Following these transactions, Daniel K. Podolsky beneficially owns a total of 38,179.908 shares of Agilent common stock.
• The transaction was made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. Insider buying, especially from a director, suggests confidence in the company's valuation and future, although this specific transaction is tied to a compensation award and dividend reinvestment rather than an open market purchase.

Positives

• A Director, Daniel K. Podolsky, increased his beneficial ownership in Agilent Technologies, Inc. by acquiring 2,158 shares of common stock.
• The acquisition demonstrates continued confidence from a key insider in the company's value, as shares were acquired at $111.75 each.
• Additional shares were acquired through a dividend reinvestment plan, further increasing the director's stake.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider buying, particularly from a director, can often be interpreted by the market as a positive signal, indicating management's belief in the company's future prospects and undervaluation at the current price. This transaction aligns with a common practice of non-employee director compensation involving equity awards.

Comparison to Industry Standards

• StockSavvy.ai observes that director stock awards and dividend reinvestment plans are standard compensation and ownership building mechanisms across many industries, including the life sciences and diagnostics sector where Agilent operates.
• The acquisition of shares at a specific market price, even if part of an award, reflects a valuation point that the insider is comfortable with, similar to how directors at companies like Thermo Fisher Scientific or Danaher Corporation might increase their holdings through similar mechanisms.

Stakeholder Impact

• Shareholders may view this increase in director ownership as a positive indicator of alignment between management and shareholder interests.
• The transaction, being part of a compensation award, reinforces the company's strategy to incentivize directors through equity, potentially impacting employee morale positively by demonstrating leadership's commitment.

Key Dates

Recommendation

While insider buying is generally a positive signal, this transaction is primarily driven by a director compensation award and dividend reinvestment, rather than a discretionary open market purchase. It indicates confidence but does not necessarily suggest a strong undervaluation that would warrant an immediate 'buy' recommendation. Investors should 'hold' and monitor further developments and broader market conditions.

Keywords

Agilent Technologies, A, Insider Transaction, Form 4, Director Stock Acquisition, Daniel K. Podolsky, Common Stock, Dividend Reinvestment Plan